Results 161 to 170 of about 49,034 (223)

Downregulation of the lncRNA PGM5P4-AS1 predicts poor prognosis and drives breast cancer progression through miR-3664-5p/KLF9. [PDF]

Cancer Biol Ther
Wu Y, Jin J, Zhang Y, Huang X, Wang H, Huang Y, Xie H.   +6 more
europepmc   +1 more source

The RRM domains of PARP14 mediate replication fork degradation in BRCA2-deficient cells. [PDF]

NAR Cancer
Hale A, Lynch KA, Dhoonmoon A, Nicolae CM, Moldovan GL.   +4 more
europepmc   +1 more source

<i>BRCA</i> and CDK4/6: allies or antagonists?-efficacy of CDK4/6 inhibitors in HR⁺/HER2^- breast cancer with germline <i>BRCA1/2</i> mutations: a narrative review. [PDF]

Transl Breast Cancer Res
Illia MF, Colucci G, Rodriguez Mignola A, Eiben M, Ballester AM, Zeff N, Paesani F, Crimi G, Von Stecher F, de la Vega M, Perazzo F, Mandó P.   +11 more
europepmc   +1 more source

Managing healthcare for female BRCA carriers in the population screening era: developing a harmonized national policy for surveillance and risk-reduction. [PDF]

Isr J Health Policy Res
Michaelson-Cohen R, Armon S, Srebnik N, Volkow EK, Mor P, Gekhtman D, Rosengarten O, Lotan AM, Goldvaser H, Miller Y, Feldman DM, Molho RB, Levy MS, Kedar I, Goldberg Y, Raz Y, Simchoni S, Hoffman A, Linial M, Carmon E, Gatot I, Braha M, Shtoyerman RC, Mordechai S, Half EE, Katz L, Levi Z, Morag SB, Allweis TM, Friedman E, Levy-Lahad E, Lieberman S.   +31 more
europepmc   +1 more source

Ovarian follicular density in women with BRCA1 and BRCA2 mutations: new insights into the negative impact on ovarian reserve. [PDF]

J Ovarian Res
Maletta M, Vicenti R, Forastiere C, Di Santo S, Doglioli M, Lenzi J, Raffone A, Cobellis L, Perandini A, Somigliana E, Seracchioli R, Raimondo D.   +11 more
europepmc   +1 more source

From genetic risk to early detection - clinical outcomes of a person-centered screening program for women with a high genetic risk of breast cancer. [PDF]

Front Oncol
Zhou K, Abadie C, Crivelli L, Fortin E, Bellanger M, Huet C.   +5 more
europepmc   +1 more source

Downregulation of TNFAIP3 Associated With Poor Prognosis and Immune Response in Breast Cancer. [PDF]

Cancer Rep (Hoboken)
Wu Y, Qin Z, Wang G.
europepmc   +1 more source

Integrated machine learning and bioinformatic analyses constructed a sulfur metabolism-related breast cancer risk model and identified heat-shock protein A9 as a potential therapeutic target for human breast cancer. [PDF]

Discov Oncol
Yuan Y, Zhang S, Fu J, Zhou F.
europepmc   +1 more source

Prognostic, chemotherapy and immunotherapy roles of GPR37/GPR37L1 in pan-cancer. [PDF]

Medicine (Baltimore)
Zhu G, He J, Shi N, Cai Z, Zhang J, Wang SCY, Li J, Zhang M, Wang Y.   +8 more
europepmc   +1 more source

Homologous recombination deficiency in newly diagnosed advanced ovarian cancer across nine Middle East countries: prevalence, real-world testing pathways, and treatment implications. [PDF]

BMC Cancer
Shash E, Vardar MA, Taskiran C, Boujassoum S, Riromar J, Aboutaleb A, Sadek F, Samy E, Bahaj W.   +8 more
europepmc   +1 more source